Business · 22/11/2013Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of New Animal Drug Applications for Roxarsone and Carbarsone
Summary
The FDA has withdrawn approval of three new animal drug applications for roxarsone or carbarsone Type A medicated articles at the sponsor's request due to the products no longer being manufactured or marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →